ConductScience.org, home

Trial · NCT02873559

Registered outcomes36

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryStand-up-and Sit-testup to 5 months (at study completion)
It is a measure of overall strength in the lower extremities. Result of the test is defined as the number of times the participant can stand up and sit from a chair in 30 seconds. There is a good correlation (r = 0.78) with a leg press and an acceptable test-retest reliability (ICC = 0.86).
SecondaryFrequency and severity of falls via questionaireAt baseline, 1 month, 5 months (at study completion)included in the monitoring of adverse events.
SecondaryBalance ability,At baseline, 1 month, 5 months (at study completion)Tandem Test containing three starting positions: 1) Standing with feet together, standing in the semi-tandem position and standing in the tandem stand. coupled with decrease risk of fall.
SecondaryAvlund mobility scaleAt baseline, 1 month, 5 months (at study completion)
Questions about experiencing fatigue and support needs of ordinary everyday activities. Avlund mobility scale is correlated with the isometric muscle strength, simple function tests , increased risk of hospitalization and mortality
SecondaryLeg extensor Power Rig testAt baseline, 1 month, 5 months (at study completion)An instrument for measuring muscle strength in the lower extremities.
SecondaryIsometric muscle strengthAt baseline, 1 month, 5 months (at study completion)Measurement of isometric muscle strength m. quadriceps in a seated leg press.
SecondaryArmflexion Test:At baseline, 1 month, 5 months (at study completion)Measures of overall strength in the upper extremities. The number of times the participant can inflect the elbow with dumbbell is measured in 30 sec.
Secondary2-minute knee lift test:At baseline, 1 month, 5 months (at study completion)Measures aerobic capacity in the elderly. Number of high knee lifts in 2 minutes.
Secondary2,45minute up-and-go test:At baseline, 1 month, 5 months (at study completion)
Target for basic mobility in the elderly. Time it takes to rise from a chair, walk around a cone 2,45m away, go back and sit down again. Moderate to good correlation between the corresponding 3m test and Berg Balance Scale (r = 0.81), walking speed (r = 0.61) and Barthel index (r = 0.78) and a good test-retest- reliability (ICC = 0.98).
SecondaryDXA scanAt baseline, 1 month, 5 months (at study completion)Lean body mass. Measurement of fat and fat-free mass and total bone mass (BMC). Executed only at baseline and at study end.
SecondaryBone Mineral DensityAt baseline, 1 month, 5 months (at study completion
Of the spine, distal forearm bilaterally, total hip bilaterally and in the skeleton as a whole (total body). In case of osteoporosis treatment will be initiated following the department's usual guidelines, which can blur the results for bone density.
SecondaryMajor Depression Inventory (MDI):At baseline, 1 month, 5 months (at study completion)Questionnaire on depression and mental well-being.
SecondaryMontreal Cognitive Assessment (MoCA):At baseline, 1 month, 5 months (at study completion)A cognitive screening test that provides an estimate of the intellectual functioning; This test is also sensitive to mild cognitive problems and dementia.
SecondaryQuality of Life EQ-5D:At baseline, 1 month, 5 months (at study completion)Questionnaire on the experienced quality of life.
SecondaryModified PISQ-12:At baseline, 1 month, 5 months (at study completion)
An assessment of sexual performance (potency) and sexual desire. There are previously found improved sexual function, mood, muscle strength and body composiAn evaluation questionnaire of sexual function
SecondaryAastrands Test:At baseline, 1 month, 5 months (at study completion)Sub-maximal fitness test performed on a treadmill. Includes monitoring heart rate
SecondaryMeasurements of the Heart Rate Variability (HRV)At baseline, 1 month, 5 months (at study completion)Studies have indicated that hypogonodal men can improve the Heart Rate Variability by testosterone treatment
SecondaryDual-energy X-ray absorptiometryAt baseline, 1 month, 5 months (at study completion)Measurement of the body composition bioimpedance.
SecondarySafety parameters - blood pressureMeasured every four weeks through the study (for 5 months)
Blood pressure. Blood samples: Serum testosterone, hemoglobin, hematocrit, lipid profile, Potassium, Natrium, creatinine, CRP, AST, bilirubin, alkaline phosphatase, TSH, p-ionized calcium, PTH, Ca ++, and 25-OH vitamin D.
SecondarySide effectsMeasured every four weeks through the study (for 5 months)Measuring a lot of posssible side effects to training and testosterone

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02873559/registered